Clinical trial
Assessing Emerald and MC10 nPoint Biosensors for Rett Syndrome
NCT04514549 is registered in ClinicalTrials.gov with Rett Syndrome Research Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Emerald and MC10 nPoint Biosensors for Rett Syndrome
- Lead sponsor
- Rett Syndrome Research Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 23, 2020
- Completion date
- March 1, 2023
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.